Evidence map›Paper›PMID 39294175›Full record

ArticleNature communications2024

Cancer cell stiffening via CoQ

Giovanni Tosi, Alessandro Paoli, Gaia Zuccolotto, Emilia Turco, Manuela Simonato, Daniela Tosoni, Francesco Tucci, Pietro Lugato, Monica Giomo, Nicola Elvassore and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. ERM Inhibition Confers Ferroptosis Resistance through ROS-Induced NRF2 Signaling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Metabolic Regulation of Ferroptosis in Breast Cancer.International journal of molecular sciences · 2025
    Review
  8. Article
  9. The MDA-MB-231 Breast Cancer Cell Secretomes Modify Metabolomes ofInternational journal of molecular sciences · 2025
    Article
  10. The Ubiquitous and Multifaceted Coenzyme Q.Antioxidants (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Giovanni TosiLaboratory of Angiogenesis and Cancer Metabolism, Department of Biology, University of Padova, Padova, Italy.ORCID 0000-0002-8250-8291
Alessandro PaoliLaboratory of Angiogenesis and Cancer Metabolism, Department of Biology, University of Padova, Padova, Italy.
Gaia ZuccolottoImmunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.
Emilia TurcoMolecular Biotechnology Center, University of Turin, Torino, Italy.
Manuela SimonatoPediatric Research Institute "Città della Speranza", Padova, Italy.
Daniela TosoniIEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-4443-1059
Francesco TucciIEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0001-6247-5392
Pietro LugatoLaboratory of Angiogenesis and Cancer Metabolism, Department of Biology, University of Padova, Padova, Italy.
Monica GiomoDepartment of Industrial Engineering, University of Padova, Padova, Italy.ORCID 0000-0002-7690-1054
Nicola ElvassoreDepartment of Industrial Engineering, University of Padova, Padova, Italy.ORCID 0000-0002-7029-6287
Antonio RosatoImmunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.ORCID 0000-0002-5263-8386
Paola CogoPediatric Research Institute "Città della Speranza", Padova, Italy.ORCID 0000-0002-6235-140X
Salvatore PeceIEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-1764-3929
Massimo M SantoroLaboratory of Angiogenesis and Cancer Metabolism, Department of Biology, University of Padova, Padova, Italy. massimo.santoro@unipd.it.ORCID 0000-0003-4605-5085

Funding

Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) 20119EC | EC Seventh Framework Programm | FP7 Ideas: European Research Council (FP7-IDEAS-ERC - Specific Programme: "Ideas" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013)) 963865EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 647057Fondazione Telethon (Telethon Foundation) GGP20003
6 · The paper itself

Abstract

CoQ

Indexed as

Breast NeoplasmsExtracellular MatrixFerroptosisSignal TransductionUbiquinoneAnimalsCell Line, TumorCell MembraneFemaleGene Expression Regulation, NeoplasticHumansLung NeoplasmsMicecoenzyme Q10Ubiquinone

Identifiers

PMID39294175
PMCPMC11410950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.